60¢sixtycents

Natera, Inc.NTRA

Is NTRA cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$330.31+6.17 (+1.90%)24:00 UTC
NASDAQHealthcare

Company snapshot

Market Cap
$47B
Large-cap
+8482%
2016 — today
10-Year Price
+2981%
2016 — today
52-Week Range
$160.21$338.70
Current $330.31· 95%

Natera develops molecular testing services globally. Its reproductive health portfolio includes Panorama (NIPT), Vistara (single-gene disorders), Horizon (carrier screening), Spectrum (IVF), Anora (miscarriage analysis), and paternity testing. Beyond reproductive health, it offers Signatera for ctDNA tumor monitoring and Prospera for organ transplant rejection. The Constellation platform provides cloud-based bioinformatics. Natera operates via direct sales and global partnerships, including BGI and Foundation Medicine.

Similar companies

Healthcare companies of comparable size to NTRA
CompanyP/EDiv yield
HUMHumana Inc.37.90.9%
BDXBecton, Dickinson and Company54.22.2%
EWEdwards Lifesciences Corporation49.5—
RVMDRevolution Medicines, Inc.-23.4—
TEVATeva Pharmaceutical Industries Limited61.4—
IDXXIDEXX Laboratories, Inc.36.5—
AAgilent Technologies, Inc.28.50.5%
ONCBeOne Medicines Ltd.4.9—

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
-242.9
N/A
Not meaningful — company is unprofitable
Sector median 25.1below sector
P/B ratio
26.0
Historically pricey
Historically pricey — last 10 years
Sector median 2.5above sector
FCF Yield
0.2%
Historically high
Historically high relative to the last 10 years
Sector median -9.6%above sector
Free · No credit card needed

Get alerted when NTRA is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.